Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Clinical pharmacogenetics polymorphism

Pharmacogenetics of Drug Metabolism Two Clinically Important Polymorphic Enzymes, CYP2D6 and TPMT... [Pg.52]

The low predictive values of pharmacogenetic tests for most polymorphic variants means there will be false positive (when PPV is low) and false negative (when NPV is low) test results. Both reduce the clinical utility of the tests. There are a number of reasons for the reduced predictive values. [Pg.173]

See other pages where Clinical pharmacogenetics polymorphism is mentioned: [Pg.490]    [Pg.20]    [Pg.112]    [Pg.12]    [Pg.114]    [Pg.951]    [Pg.951]    [Pg.46]    [Pg.54]    [Pg.170]    [Pg.4]    [Pg.29]    [Pg.128]    [Pg.252]    [Pg.288]    [Pg.291]    [Pg.369]    [Pg.372]    [Pg.516]    [Pg.96]    [Pg.179]    [Pg.278]    [Pg.210]    [Pg.215]    [Pg.221]    [Pg.239]    [Pg.22]    [Pg.28]    [Pg.41]    [Pg.46]    [Pg.50]    [Pg.57]    [Pg.83]    [Pg.139]    [Pg.143]    [Pg.272]    [Pg.293]    [Pg.365]    [Pg.369]    [Pg.379]    [Pg.405]    [Pg.434]    [Pg.60]    [Pg.64]    [Pg.13]    [Pg.207]    [Pg.191]   
See also in sourсe #XX -- [ Pg.188 ]



SEARCH



Clinical pharmacogenetics

Clinical pharmacogenetics genetic polymorphisms

Pharmacogenetic

Pharmacogenetics

Pharmacogenetics polymorphisms

© 2024 chempedia.info